159 related articles for article (PubMed ID: 8828023)
21. Clinical efficacy of ebastine in the treatment and prevention of seasonal allergic rhinitis.
Peláez A
Drugs; 1996; 52 Suppl 1():35-8. PubMed ID: 8828025
[TBL] [Abstract][Full Text] [Related]
22. [Ebastine in the treatment of seasonal allergic rhinitis].
Il'ina NI; Balabolkin II; Blokhin BM; Goriachkina LA; Kolganova NA; Pampura AN; Sidorenko IV
Ter Arkh; 1998; 70(9):79-81. PubMed ID: 9821236
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.
Ratner P; Hampel F; Gispert J
Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):111-5. PubMed ID: 12731456
[TBL] [Abstract][Full Text] [Related]
24. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
25. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Van Cauwenberge P; De Belder T; Sys L
Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
[TBL] [Abstract][Full Text] [Related]
27. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
Frossard N; Melac M; Benabdesselam O; Pauli G
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
[TBL] [Abstract][Full Text] [Related]
28. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
[TBL] [Abstract][Full Text] [Related]
29. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
Bousquet J; Gaudaño EM; Palma Carlos AG; Staudinger H
Allergy; 1999 Jun; 54(6):562-8. PubMed ID: 10435469
[TBL] [Abstract][Full Text] [Related]
30. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
Wiseman LR; Faulds D
Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
[TBL] [Abstract][Full Text] [Related]
31. A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients.
Ankier SI; Warrington SJ
J Intern Med; 1989 Dec; 226(6):453-8. PubMed ID: 2577377
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group.
Sabbah A; Daele J; Wade AG; Ben-Soussen P; Attali P
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):319-25. PubMed ID: 10541424
[TBL] [Abstract][Full Text] [Related]
35. [Ebastine vs terfenadine in allergic rhinitis].
Terán Ortíz L; Flores Sandoval G; Orea Solano M; Camarena A
Rev Alerg; 1993; 40(4):82-5. PubMed ID: 7908244
[TBL] [Abstract][Full Text] [Related]
36. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
Martínez-Cócera C; De Molina M; Martí-Guadaño E; Pola J; Conde J; Borja J; Pérez I; Arnaiz E; Izquierdo I;
J Investig Allergol Clin Immunol; 2005; 15(1):22-9. PubMed ID: 15864879
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
38. The clinical efficacy of H1 antagonists in urticaria and rhinitis.
Rihoux JP; Donnelly F; Burtin B
J Allergy Clin Immunol; 1998 Aug; 102(2):333-4. PubMed ID: 9723686
[No Abstract] [Full Text] [Related]
39. Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma.
Aubier M; Neukirch C; Peiffer C; Melac M
Allergy; 2001 Jan; 56(1):35-42. PubMed ID: 11167350
[TBL] [Abstract][Full Text] [Related]
40. Ebastine in perennial allergic rhinitis.
Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
